Achieve Life Sciences announces common stock, warrants offering

Achieve Life Sciences (ACHV) announced a proposed underwritten public offering in which it intends to offer and sell shares of its common stock and accompanying common warrants to purchase common stock. All of the securities are being offered by Achieve. Achieve intends to use the proceeds from the offering to fund continued advancement of cytisinicline through potential FDA marketing approval of cytisinicline and for working capital and general corporate purposes. Citizens Capital Markets and Raymond James are acting as the joint book-running managers for the proposed offering. Lake Street Capital Markets is acting as financial advisor to Achieve in the proposed offering.